TWO SIGMA INVESTMENTS, LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 45 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,295
+14.1%
39,405
-13.3%
0.00%
Q1 2023$7,273
-70.7%
45,455
+1.6%
0.00%
Q4 2022$24,830
-14.4%
44,738
+84.2%
0.00%
Q3 2022$29,000
-67.8%
24,289
-83.0%
0.00%
Q2 2022$90,000
-80.3%
143,098
-64.3%
0.00%
-100.0%
Q1 2022$457,000
-61.6%
401,277
-24.1%
0.00%
-66.7%
Q4 2021$1,189,000
-76.8%
528,370
-64.7%
0.00%
-72.7%
Q3 2021$5,122,000
+34.4%
1,497,792
+17.5%
0.01%
+22.2%
Q2 2021$3,810,000
+13.7%
1,274,266
+22.8%
0.01%0.0%
Q1 2021$3,352,000
+254.3%
1,037,631
+132.6%
0.01%
+200.0%
Q4 2020$946,000
+7783.3%
446,149
+3168.3%
0.00%
Q2 2020$12,000
-20.0%
13,651
-25.2%
0.00%
Q1 2020$15,000
-44.4%
18,251
-34.0%
0.00%
Q4 2019$27,000
-22.9%
27,651
-19.5%
0.00%
Q3 2019$35,000
-49.3%
34,351
-10.7%
0.00%
Q2 2019$69,000
-13.8%
38,448
-9.7%
0.00%
Q1 2019$80,000
-25.9%
42,574
-53.4%
0.00%
Q4 2018$108,000
-43.5%
91,296
+29.4%
0.00%
-100.0%
Q3 2018$191,000
+664.0%
70,575
+344.0%
0.00%
Q2 2017$25,000
-82.5%
15,897
-85.2%
0.00%
-100.0%
Q2 2016$143,000
-92.4%
107,301
-4.0%
0.00%
-90.0%
Q4 2014$1,889,000111,8120.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders